Use of artificial intelligence chatbots in clinical management of immune-related adverse events.
Journal:
Journal for immunotherapy of cancer
PMID:
38816231
Abstract
BACKGROUND: Artificial intelligence (AI) chatbots have become a major source of general and medical information, though their accuracy and completeness are still being assessed. Their utility to answer questions surrounding immune-related adverse events (irAEs), common and potentially dangerous toxicities from cancer immunotherapy, are not well defined.